Graduated from Guangdong Pharmaceutical University with a master's degree, majoring in pharmacy, and his main research directions are virus cell biology and genetic engineering and pharmacy. He has participated in research on anti-tumor immunotherapy based on Crispr, and has rich experience in molecular biology and cell biology experiments.
Optimistic and cheerful, with team spirit.
1.Wang H, Lu H, Lei YS, Gong CY, Chen Z, Luan YQ, Li Q, Jian YZ, Wang HZ, Wu FL, Tao CL, Shen H, Bo HB, Shao HW, Zhang WF. Development of a Self-Restricting CRISPR-Cas9 System to Reduce Off-Target Effects. Mol Ther Methods Clin Dev.18:390-401（2020）.